Skip to main content
Fig. 6 | Journal of Hematology & Oncology

Fig. 6

From: Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib

Fig. 6

Nano-sar suppresses Src activation and the downstream pathways more efficiently in head and neck tumors than the free drug in mice. a–c The effects of saracatinib (Sar) or Nano-sar on Src signaling pathways in head and neck tumors. The representative IHC images were shown in the left panel and quantification of IHC staining with Image pro-Plus6.0 was shown in the right panel. *p < 0.05; **p < 0.01

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us